Can nature's defence against malaria be mimicked by the development of host-directed therapies?

Pharmacogenomics Journal

Volumn 4, Issue 3, 2004, Pages 141-142

  Foote, S J ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ERYTHROCYTE BAND 3 PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOPHORIN C; HEMOGLOBIN S; PYRUVATE KINASE;

BLOOD GROUP DUFFY SYSTEM; GENE MUTATION; GENETIC POLYMORPHISM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HOMOZYGOSITY; HOST PARASITE INTERACTION; HUMAN; MALARIA; NOTE; NUCLEIC ACID BASE SUBSTITUTION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROMOTER REGION; SICKLE CELL ANEMIA; THALASSEMIA;

ANIMALS; ANTIMALARIALS; HOST-PARASITE RELATIONS; HUMANS; MALARIA; PLASMODIUM VIVAX;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 2942755648     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500241     Document Type: Note

References (6)

1. Mgone CS et al. Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. Trans R Soc Trop Med Hyg 1996; 90: 228-231.
2. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976; 295: 302-304.
3. Patel SS et al. The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood 2001; 98: 3489-3491.
4. Luzzatto L, Usanga FA, Reddy S. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science 1969; 164: 839-842.
5. Min-Oo G et al. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 2003; 35: 357-362.
6. Peters W. Chemotherapy and Drug Resistance in Malaria. Academic Press: London 1970.